Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report - ScienceDirect
Anti-Yo Associated Paraneoplastic Cerebellar Degeneration in a Man with Large Cell Cancer of the Lung – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
CDR2 and CDR2L | Paraneoplastic Neurological Syndromes (PNS) research group | UiB
Frontiers | Case Report: A False Negative Case of Anti-Yo Paraneoplastic Myelopathy
Paraneoplastic cerebellar degeneration and endometrial cancer: a rare occurrence
Frontiers | Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications
Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies | British Journal of Cancer
Complex HLA association in paraneoplastic cerebellar ataxia with anti-Yo antibodies - ScienceDirect
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration - Kråkenes - 2019 - Annals of Neurology - Wiley Online Library
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar Degeneration | Neurology Neuroimmunology & Neuroinflammation
Bergen Open Research Archive: Cerebellar degeneration-related proteins in anti-Yo associated paraneoplastic cerebellar degeneration
Paraneoplastic Cerebellar Degeneration Associated with Anti-Yo Antibodies Appearing as a Leptomeningeal Cerebellar Carcinomatosis at MRI: a Case Report | SpringerLink
Characterization of the immune contexture of Yo-PCD ovarian tumors. a... | Download Scientific Diagram
Anti-Yo antibody-positive paraneoplastic cerebellar degeneration in a patient with possible cholangiocarcinoma: A case report and review of the literature
PDF) Rehabilitation for a patient with anti-Yo antibody-positive paraneoplastic cerebellar degeneration caused by breast cancer: A case report and literature review
Anti-Yo Antibody-mediated Paraneoplastic Cerebellar Degeneration in a Female Patient with Pleural Malignant Mesothelioma
Yo antibody binding to CDR2 impacts cannabinoid 1 receptor activity.... | Download Scientific Diagram
PDF) PARANEOPLASTIC CEREBELLAR DEGENERATION (PCD) IN EXTENSIVE STAGE SCLC IN REMISSION
Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo–associated paraneoplastic ce
Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration - Journal of Neuroimmunology
French Reference Center for PNS and AE on Twitter: "Proud of our medical Doctor Elise Peter that received the poster Price for the session "immunotherapy and clinics" on anti-Yo cancer with paraneoplastic